A Prospective Study on the Application of Endometrial Cytology Examination in the Screening of Endometrial Cancer
- Authors
-
-
Zheng Fang
Department of Obstetrics and Gynaecology, Zhaoqing No. 2 People’s Hospital, Zhaoqing City, Guangdong Province, 526060, China -
Du Lianfang
Department of Obstetrics and Gynaecology, Zhaoqing No. 2 People’s Hospital, Zhaoqing City, Guangdong Province, 526060, China -
Xie Cuiqi
Department of Obstetrics and Gynaecology, Zhaoqing No. 2 People’s Hospital, Zhaoqing City, Guangdong Province, 526060, China -
Shao Shaowei
Department of Obstetrics and Gynaecology, Zhaoqing No. 2 People’s Hospital, Zhaoqing City, Guangdong Province, 526060, China -
Luo Qiaoming
Department of Obstetrics and Gynaecology, Zhaoqing No. 2 People’s Hospital, Zhaoqing City, Guangdong Province, 526060, China -
Li Qiyan
Department of Obstetrics and Gynaecology, Zhaoqing No. 2 People’s Hospital, Zhaoqing City, Guangdong Province, 526060, China -
Ma Ling
Department of Obstetrics and Gynaecology, Zhuhai Maternal and Child Health Care, Zhuhai City, Guangdong Province, 519000, China
-
- Keywords:
- Â Endometrial cytology, endometrial sampling device for cytology, endometrial cancer, thinprep cytology test.
- Abstract
-
Background: Endometrial cancer is one of the most common gynecology malignancies. But there is still lack of an accurate, reliable, convenient, easy, economical and practical method for early detection of endometrial cancer and precancerous lesions. The aim of this study is to evaluate the specimen quality and diagnostic accuracy of endometrial cytology examination in the screening of endometrial cancer.
Methods: 95 patients with abnormal uterine bleeding or vaginal ultrasound examination results indicating intrauterine abnormalities and needing endometrial examination were investigated, and specimens were collected using endometrial sampling device for cytology (ESDC) and sliced using thinprep cytology test (TCT), meanwhile, hysteroscopy auxiliary diagnostic curettage and histopathological examination were performed.
Results: The satisfaction rate was 100% for the specimens collected using ESDC and 97.9% for those using diagnostic curettage. The difference in the satisfaction rate of collecting specimens was statistically significant between the two methods, and the satisfaction rate of collecting specimen using endometrial cytology was superior to that using diagnostic curettage. Taking diagnostic curettage histopathologic results as "gold standard", the sensitivity of endometrial cytology was 63.6%, specificity 93.6%, positive predictive value 70% and negative predictive value 95.2% in the screening of endometrial cancer.
Conclusion: Endometrial cytology can be used as a reliable, safe and simple method in the screening of endometrial cancer.
- Downloads
-
Download data is not yet available.
- References
-
DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians 2014; 64: 252-71. http://dx.doi.org/10.3322/caac.21235
Nakagawa-Okamura C, Sato S, Tsuji I, Kuramoto H, Tsubono Y, Aoki D, et al. Effectiveness of mass screening for endometrial cancer. Acta cytologica 2002; 46: 277-83. http://dx.doi.org/10.1159/000326722
Papaefthimiou M, Symiakaki H, Mentzelopoulou P, Tsiveleka A, Kyroudes A, Voulgaris Z, et al. Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology. Cancer 2005; 105: 56-64. http://dx.doi.org/10.1002/cncr.21025
Norimatsu Y, Kouda H, Kobayashi TK, Moriya T, Yanoh K, Tsukayama C, et al. Utility of thin-layer preparations in the endometrial cytology: evaluation of benign endometrial lesions. Annals of Diagnostic Pathology 2008; 12: 103-11. http://dx.doi.org/10.1016/j.anndiagpath.2007.05.005
Fan B, Zhao Q, Zhang S, Wang T, Deng X. Assessment of transvaginal sonography combined with endometrial cytology as a mass screening method for endometrial cancer in Beijing. The Journal of International Medical Research 2010; 38: 803-9. http://dx.doi.org/10.1177/147323001003800307
Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. American Journal of Obstetrics and Gynecology 1996; 174: 1678-82. http://dx.doi.org/10.1016/S0002-9378(96)70196-5
Yang X, Liao QP, Wu C, Zhang NY, Zhao J, Chen R, et al. [Screening and sampling of endometrial carcinoma accuracy of the endometrial cytology test for the screening of endometrial cancer]. Zhonghua fu chan ke za zhi 2013; 48: 884-90.
Remondi C, Sesti F, Bonanno E, Pietropolli A, Piccione E. Diagnostic accuracy of liquid-based endometrial cytology in the evaluation of endometrial pathology in postmenopausal women. Cytopathology: Official Journal of the British Society for Clinical Cytology 2013; 24: 365-71. http://dx.doi.org/10.1111/cyt.12013
Kipp BR, Medeiros F, Campion MB, Distad TJ, Peterson LM, Keeney GL, et al. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study. Cancer 2008; 114: 228-35. http://dx.doi.org/10.1002/cncr.23636
Buccoliero AM, Gheri CF, Castiglione F, Garbini F, Barbetti A, Fambrini M, et al. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women. Cytopathology: official journal of the British Society for Clinical Cytology 2007; 18: 241-9. http://dx.doi.org/10.1111/j.1365-2303.2007.00463.x
Fujiwara H, Takahashi Y, Takano M, Miyamoto M, Nakamura K, Kaneta Y, et al. Evaluation of endometrial cytology: cytohistological correlations in 1,441 cancer patients. Oncology 2015; 88: 86-94. http://dx.doi.org/10.1159/000368162
- Downloads
- Published
- 29-04-2015
- Section
- Articles
How to Cite
Similar Articles
- F. Gloria-Bottini, M. Nicotra, C. Spina, P.L. Benedetti-Panici, P. Saccucci, A. Neri, A. Magrini, E. Bottini, P53 Codon 72 and Endometrium Cancer , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Shashi K. Agarwal, Exercise: Preventive and Therapeutic Benefits in Cancer , Journal of Cancer Research Updates: Vol. 10 (2021)
- César Paz-y-Miño, Carolina Salazar, Tania Zurita, Andrés López-Cortés, Ramiro Hidalgo, Felipe Rosales, Alexandra Montalvo, Paola E. Leone, Positive Association between the Polymorphic Variant CCND1 A870G and Colorectal Cancer in Ecuadorian Mestizo Population , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Satoshi Hibi, Yuko Shirokawa, Kengo Nanya, Tatsuya Kawamura, Yuko Kato, Shu Yuasa, Satoshi Kayukawa, Kenji Ina, Evaluation of HBV-DNA Monitoring after Completion of Chemotherapy using a PDCA Cycle following Introduction of a Support System Provided by a Multidisciplinary Team of Quality Management in Cancer Medicine , Journal of Cancer Research Updates: Vol. 14 (2025)
- Muqaddam Shohzodaeva, Uldoshev Ravshan Zohidovich, Rachel Kansiime, Joyeeta Talukdar, From Hidden Burden to Visible Care: Integrating Psycho-Oncology into Breast Cancer Control in Tajikistan through Indian and African Models , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Fatma F. Abdel Hamid, Mahmoud K. Singer, Mahmoud N. El-Rouby, Mahmoud M. Said, Reda H. Tabashy, Motawa E. El-Houseini, HepG2 Attenuation Induced by RNase A Modulates Gene Profiling and Immunophenotypic Characterization of Some Immune Cells Operating in Cancer Vaccine , Journal of Cancer Research Updates: Vol. 7 No. 1 (2018)
- Sisir Nandi, Manish C. Bagchi, EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Kawakeb N. Abdulla, Rasha Kareem Khudhur, Ali Muafaq Said, Azal Hamoody Jumaa, Youssef Shakuri Yasin, Laetrile and Methotrexate: A Dual-Drug Approach to Inhibiting Cervical Cancer Cell Proliferation , Journal of Cancer Research Updates: Vol. 14 (2025)
- Janet Wangari-Talbot, Elizabeth Hopper-Borge, Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Kenji Ina, Ryuichi Furuta, Megumi Kabeya, Takashi Yoshida, Takae Kataoka, Satoshi Kayukawa, S-1 Plus Leucovorin and Oxaliplatin in Combination with Lentinan as First-line Therapy in Patients with Metastatic Gastric Cancer , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
You may also start an advanced similarity search for this article.